Tal Zaks Ph.D

Tal Zaks Ph.D General Information

Biography

Dr. Tal Zaks serves as Partner at OrbiMed. Dr. Tal Zaks serves as the Chief Medical Officer at Moderna Therapeutics. He serves as Board Member at MinervaX. He oversees preclinical development, clinical development, and regulatory affairs across Moderna and its ventures. He served as the Interim Chief Medical Officer at Valera. Prior to joining Moderna, Dr. Zaks was senior vice president and head of Global Oncology at Sanofi, where he was responsible for all aspects of oncology drug discovery, development and commercialization. Dr. Zaks began his industry career at GlaxoSmithKline in the genetics research group, where he built the oncology translational medicine team and led translational research on lapatinib as well as the in-licensing and clinical development of foretinib. In addition to his industry work, Dr. Zaks is an associate professor of medicine at the University of Pennsylvania and has served as a volunteer physician at the Philadelphia Veterans Administration Medical Center, treating patients with genitourinary cancers. Dr. Zaks received his M.D. and Ph.D. from Ben Gurion University in Israel and conducted post-doctoral research at the U.S. National Institutes of Health. He completed his clinical training in internal medicine at Temple University Hospital followed by a fellowship in medical oncology at the University of Pennsylvania.